Revance Therapeutics Market Cap

NGX:DEAPCAP has a market cap or net worth of 1.80 billion as of August 1, 2025. Its market cap has increased by 122.22% in one year.

Market Cap

1.80B

Enterprise Value

2.23B

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$1.20

Market Cap Chart

Since January 30, 2008, NGX:DEAPCAP's market cap has decreased from 7.86T to 1.80B, a decrease of -99.98%. That is a compound annual growth rate of -38.03%.

Market Cap History

Date	Market Cap	% Change
Aug 1, 2025	1.80B	1.69%
Dec 31, 2024	1.77B	103.45%
Dec 29, 2023	870.00M	190.00%
Dec 30, 2022	300.00M	-
Dec 30, 2021	300.00M	-20.00%
Dec 31, 2020	375.00M	-37.50%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
MTN Nigeria Communications	9,897.90B
Dangote Cement	8,850.16B
BUA Foods	8,701.20B
BUA Cement	4,571.69B
Zenith Bank	3,141.84B
Geregu Power	2,853.75B
Guaranty Trust Holding Company	2,501.00B
Lafarge Africa	2,400.06B

Market Cap Rankings